Laurel A. King

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Mitotic Count, Nuclear Atypia, and Immunohistochemical Determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 Expression in Granulosa Cell Tumors of the Ovary: Mitotic Count and Ki-67 Are Indicators of Poor Prognosis

Laurel A. King, Takashi Okagaki, Donald G. Gallup et al. · Gynecologic Oncology · 1996 · 84 citations

Medicine, Oncology, Pathology +17

Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix

Laurel A. King, Toru Tase, Leo B. Twiggs et al. · Cancer · 1989 · 71 citations

Medicine, Oncology, Pathology +17

PHIT for Duty, a Mobile Application for Stress Reduction, Sleep Improvement, and Alcohol Moderation

Paul N. Kizakevich, Randall Eckhoff, Janice M. Brown et al. · Military Medicine · 2018 · 34 citations · Full text

Nursing, Health Promotion, Psychology +17

Large Loop Excision of the Transformation Zone (LLETZ): A Pathologic Evaluation

Marx J. Messing, Luther B. Otken, Laurel A. King et al. · Gynecologic Oncology · 1994 · 29 citations

Medicine, Plastic Surgery, Regional Anatomy +2